spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Transcatheter Mitral Valve 

 HSMN NewsFeed - 8 May 2024
4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 Aug 2023
Nyra Medical names Lori Chmura as Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 31 Mar 2022
4C Medical Technologies Completes $35 Million Series C Financing and Appoints Saravana Kumar as President and CEO
Devices Cardiology Personnel Venture Capital
 HSMN NewsFeed - 27 Jan 2022
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Sep 2021
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 25 Aug 2021
Baylis Medical Announces First Clinical Case Using the VersaCross(R) Large Access Solution in Canada
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2021
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 1 Dec 2020
Study Finds TMVR Procedural Efficiency with use of the VersaCross(R) RF Transseptal Solution
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Sep 2020
Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System(R)
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 24 Sep 2020
InnovHeart Reports Successful First-in-Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2020
Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation
Devices Cardiology Interventional Regulatory
 HSMN NewsFeed - 9 Apr 2020
Abbott's TriClip(TM) Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 30 Jan 2020
Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Sep 2019
REDUCE FMR Study Shows Cardiac Dimensions' Carillon(R) System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2019
Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDA
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 1 Jul 2019
Cardiac Dimensions Reaches 1,000 Implants Of Carillon(R) System, A Minimally Invasive Treatment For Functional Mitral Regurgitation
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2019
Edwards Announces Milestones For Transcatheter Mitral Program
Devices Cardiology Interventional
 HSMN NewsFeed - 21 Mar 2019
Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara(TM)
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Feb 2019
Neovasc Provides Corporate Update
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Feb 2019
Pierangeli Clinic Initiates Program Providing Neovasc Reducer(TM) Procedure to Italian Patients with Refractory Angina
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jan 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Oct 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Sep 2018
InnovHeart Elects Keith D. Dawkins MD as Chairman of the Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 26 Jul 2018
Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jun 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jun 2018
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
Devices Cardiology Personnel
 HSMN NewsFeed - 25 May 2018
Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2018
Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Mar 2018
Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation
Devices Cardiology Reimbursement
 HSMN NewsFeed - 1 Feb 2018
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 22 Jan 2018
Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 6 Nov 2017
Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 Dec 2016
Neovasc Provides Update on its Tiara(TM) Mitral Valve Clinical Program
Devices Cardiology Surgery
 HSMN NewsFeed - 8 Oct 2015
Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 29 Dec 2014
Jean Boulle Group Reports Successful First Clinical Trial Implant of the Tendyne Transcatheter Mitral Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Dec 2014
Jean Boulle Group Announces Successful First Human Implants of the Nickel-Titanium Tendyne Transcatheter Mitral Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Oct 2014
Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara(TM) Transcatheter Mitral Valve
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 Apr 2014
CardiAQ(TM) Valve Technologies Inc. (CardiAQ) appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance & Clinical Affairs
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 6 Mar 2014
Edwards Lifesciences Announces First Human Implants With Mitral Transcatheter Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Feb 2014
Neovasc Inc. Announces Successful First Human Implant of Tiara(TM) Transcatheter Mitral Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2013
Eleven Patients Treated with the Cardioband Annuloplasty System for Transcatheter Mitral Repair Show Promising Preliminary Results
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2013
David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2013
Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Nov 2012
Neovasc Inc. Finalizes US $4.6 Million Agreement Giving Lemaitre Vascular Rights to In-House Manufacture of Xenosure(R) Surgical Patch
Devices Surgery Licensing
 HSMN NewsFeed - 14 Jun 2012
CardiAQ(TM) Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2012
Micro Interventional Devices, Inc. Secures Bridge Financing to Advance Clinical Development of Permaseal(TM)
Devices Surgery Cardiology Venture Capital
 HSMN NewsFeed - 9 Feb 2011
CardiAQ Valve Technologies (CVT) appoints Dr. Kalathi Thyagarajan as Vice President of Regulatory Affairs & Quality Assurance
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 7 Jan 2011
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 1 Jun 2010
CardiAQ Valve Technologies ("CVT") Completes Move of Its Headquarters to a Specialized Facility in Irvine, Calif., and Announces Expansion of Its Product Development Team
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2010
CardiAQ Valve Technologies ("CVT") to Disclose Data During "EuroPCR 2010" About the World's First Successful In Vivo Transcatheter Delivery of a Mitral Heart Valve Implant
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Feb 2010
Valtech Cardio Ltd. Announces Appointment of CEO -- Medtech Veteran Bruce H. KenKnight Joins Valtech Team
Devices Cardiology Personnel
 HSMN NewsFeed - 12 Jan 2010
CardiAQ Valve Technologies (CVT) Closes $6.5 Million 'Series A' Funding for Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Sep 2009
CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
Devices Interventional Cardiology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.